Additionally, inhibiting IL-10 expression or function can also reduce tumor invasiveness and metastasis, thereby improving patient prognosis (Cai and Zhang, 2016; Rossowska et al., 2018; Huang et al., 2020). The gene discussed is IL10; the disease is neoplasm.